hypogonadotropic hypogonadism

Search with Google Search with Bing
Information
Disease name
hypogonadotropic hypogonadism
Disease ID
DOID:0090070
Description
"A hypogonadism characterized by a impaired signalling by gonadotrpin relasing hormone." [url:https\://www.ncbi.nlm.nih.gov/pubmed/17761590]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
NR0B1 X 30,304,206 30,309,390 12
SOX2 3 181,711,925 181,714,436 4
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04456296 Completed Phase 4 A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism June 30, 2020 July 12, 2023
NCT01438034 Completed Phase 1 Kisspeptin in the Evaluation of Delayed Puberty June 8, 2013 September 10, 2021
NCT01438073 Completed Phase 1 Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling September 2011 April 2016
NCT01623570 Completed N/A Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP March 2011 June 2012
NCT01709331 Completed Phase 3 A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) February 11, 2013 April 8, 2015
NCT02062307 Completed Bone Mineral Markers in Hypogonadism August 2012 August 2013
NCT02110368 Completed Phase 3 Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions March 2014 May 2014
NCT02154477 Completed Phase 1/Phase 2 Effect of Intranasal Insulin on LH Concentrations in Man December 2014 December 2017
NCT00392756 Completed Phase 1 Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS) April 1989 May 16, 2019
NCT02730169 Completed Phase 2 Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism May 12, 2016 May 19, 2018
NCT02908074 Completed Phase 2 A 6 Month Safety Extension Study of MBGS205 November 15, 2016 November 21, 2018
NCT03019575 Completed Phase 3 Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043) February 2, 2017 May 5, 2020
NCT05752591 Completed Hypothalamic-pituitary Dysfunction in Diabetes May 25, 2018 March 14, 2024
NCT00494169 Completed Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders January 1999 February 2022
NCT00697814 Completed Phase 2 Clomiphene in Males With Prolactinomas and Persistent Hypogonadism June 2004 June 2005
NCT01403532 Completed Phase 4 Sequential Therapy for Hypogonadotropic Hypogonadism September 2009 December 2012
NCT04975334 Enrolling by invitation Phase 2 Opioid Antagonism in Hypogonadotropic Hypogonadism August 31, 2024 May 31, 2025
NCT06357442 Not yet recruiting Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant. April 2024 April 2025
NCT04252001 Not yet recruiting N/A Growing up With the Young Endocrine Support System (YESS!) December 1, 2024 December 1, 2026
NCT05633966 Recruiting Phase 1 Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders December 16, 2022 December 2024
NCT01952782 Recruiting Phase 1 Neuropeptides in Human Reproduction April 30, 2014 August 2025
NCT00914823 Recruiting Phase 1 Kisspeptin Administration in the Adult June 23, 2009 August 2025
NCT05971836 Recruiting The Molecular Basis of Inherited Reproductive Disorders January 21, 2021 March 2026
NCT05808647 Recruiting N/A Low Energy Availability and Pituitary Function (LEAP Study) April 2023 January 2025
NCT01601171 Recruiting Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate March 2012 March 2030
NCT04648969 Recruiting Phase 2 Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism January 20, 2021 May 31, 2025
NCT05896293 Recruiting Phase 2 Kisspeptin Administration Subcutaneously to Patients With IHH February 3, 2023 June 30, 2027
NCT02369796 Terminated Phase 2 A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism February 2015 November 2015
NCT01155518 Terminated Phase 2 Hypogonadism in Young Men With Type 2 Diabetes June 2010 December 2013
NCT00328926 Terminated Phase 4 Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L]) March 2006 May 2012
NCT03118479 Terminated Phase 1 Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) May 2010 September 1, 2010
NCT05205837 Terminated Phase 4 A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial November 24, 2021 August 15, 2023
NCT05184374 Unknown status N/A Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH January 1, 2022 December 31, 2022
NCT02880280 Unknown status Phase 4 Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism August 2016 December 2018
NCT02705014 Unknown status N/A Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome January 2016 August 2017
NCT00456274 Unknown status N/A Baselines in Reproductive Disorders September 1999 September 2020
NCT00383656 Unknown status Phase 2 Pulsatile GnRH in Anovulatory Infertility January 1989 September 2020
Disase is a (Disease Ontology)
DOID:1924
Cross Reference ID (Disease Ontology)
ICD10CM:E23.0
Cross Reference ID (Disease Ontology)
MIM:PS147950
Cross Reference ID (Disease Ontology)
ORDO:432
Cross Reference ID (Disease Ontology)
ORDO:478
Exact Synonym (Disease Ontology)
congenital idiopathic hypogonadotropic hypogonadism
Exact Synonym (Disease Ontology)
hypogonadotropism
Exact Synonym (Disease Ontology)
isolated congenital gonadotropin deficiency